GPRC5D and plasma cell myeloma: For instance, loss of GPRC5D was a common finding in multiple myeloma resistance to therapy,31,32 whereas loss of BCMA was a less frequent event.33 This is hypothesized to be due to the relative importance of BCMA to the survival of the myeloma cells compared to GPRC5D.